Hye Duck Choi

6PUBLICATIONS
0CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)PharmacogenomicsSocial epidemiologyBehavioural epidemiologyMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (6)

|Jun 16, 2023
Drug-Drug interactions of docetaxel in patients with breast cancer based on insurance claims data.

Kwang-Hee Shin, Young-Mi Ah, Sang Hun Cha

|Jan 27, 2023
An Updated Meta-Analysis for Safety Evaluation of Alirocumab and Evolocumab as PCSK9 Inhibitors.

Hye Duck Choi, Ji Hae Kim

|Mar 04, 2022
Comparative safety and efficacy of low- or moderate-intensity statin plus ezetimibe combination therapy and high-intensity statin monotherapy: A meta-analysis of randomized controlled studies.

Young-Mi Ah, Minseob Jeong, Hye Duck Choi

|Dec 20, 2021
Comparison of Efficacy and Safety of Statin-Ezetimibe Combination Therapy with Statin Monotherapy in Patients with Diabetes: A Meta-Analysis of Randomized Controlled Studies.

Kwang-Hee Shin, Hye Duck Choi

|Jul 15, 2020
Eye, hepatobiliary, and renal disorders of erlotinib in patients with non-small-cell lung cancer: A meta-analysis.

Hye Duck Choi, Min Jung Chang

|Aug 22, 2017
Cardiac toxicities of lapatinib in patients with breast cancer and other HER2-positive cancers: a meta-analysis.

Hye Duck Choi, Min Jung Chang

Pageof 1

Frequent Collaborators